zoeti inc nyse price perfect result hold
adjust ep exclud certain amort restructur one-tim item
zoeti locat parsippani nj world largest anim health compani medicin product
februari zoeti report better-than-expect result revenu adjust ep
vs despit strong lower ep estim dime expect
earn per share vs guidanc grow per share
get readi trio strong result led companion portfolio
continu growth dermatolog simparica livestock saw
continu pressur cattl swine partial off-set growth poultri ep aid favor
tax rate quarter due certain one-tim item zoeti expect grow revenu ahead
market across speci asid cattl possibl swine focu companion busi
pend approval/launch simparica trio continu expect us approv quarter launch
week eu launch begin month product contribut net benefit
lower estim lower ep estim dime due flat gross margin higher
interest/oth expens increas sg spend support compani expans lab-bas
diagnost manag cite hit earn mani factor continu impact
earn also lower dime per share
price perfect despit give ep guidanc estim share trade
yesterday market compani trade ebitda estim
ep understand excit simparica trio first triple-therapi enter
us flea/tick/heartworm market current valuat appear leav margin error term approv
launch time execut
maintain hold recommend share price perfect compani certainli deserv
credit best-in-class develop portfolio appear sever year ahead competitor hard
justifi valuat ebitda estim
million except per share
exclud certain non-cash item restructur certain one-tim item
compani file research estim
million except per share
current market discount pmv
after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst receiv
direct indirect compens express specif recommend view report
public data februari rate buy
chang hold may
